Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous KRAS mutant TCR-transduced PBLs |
Trade Name | |
Synonyms | |
Drug Descriptions |
Autologous KRAS mutant TCR-transduced PBLs are peripheral blood lymphocytes engineered to express a T-cell receptor (TCR) specific for a KRAS mutation, which potentially induce cytotoxic T-lymphocyte (CTL)-dependent killing of tumor cells expressing mutant KRAS (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C204252 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + Autologous KRAS mutant TCR-transduced PBLs | Aldesleukin Autologous KRAS mutant TCR-transduced PBLs | 0 | 1 |
Autologous KRAS mutant TCR-transduced PBLs | Autologous KRAS mutant TCR-transduced PBLs | 0 | 0 |